Altria vs Keurig Dr Pepper
Side-by-side comparison of AI visibility scores, market position, and capabilities
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
About
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Burlington MA beverages (NASDAQ: KDP) at $15.35B FY2024 revenue (+3.6%); Dr Pepper/7UP/Snapple + Keurig K-Cup, 82% FCF growth, 2025 guidance mid-single-digit growth competing with Coca-Cola and PepsiCo.
About
Keurig Dr Pepper Inc. is a Burlington, Massachusetts-based beverage company — publicly traded on NASDAQ (NASDAQ: KDP) as an S&P 500 Consumer Staples component — manufacturing, marketing, and distributing hot beverages (coffee through the Keurig single-serve system and Green Mountain roasted coffee brands), cold beverages (Dr Pepper, 7UP, Snapple, Canada Dry, A&W, Sunkist, Bai, Core, Clamato, Mott's, Hawaiian Punch, Penafiel), and producing/selling the Keurig K-Cup system (over 500 varieties of licensed K-Cup pods from 75+ coffee brands) through approximately 27,000 employees. In fiscal year 2024, Keurig Dr Pepper reported revenue of $15.35 billion (+3.6% year-over-year), adjusted diluted EPS growth of 8%, operating cash flow growth of 67% to $2.2 billion, and free cash flow growth of 82% to $1.7 billion. For 2025, KDP guided mid-single-digit net sales growth and high-single-digit adjusted EPS growth, reflecting continued volume growth in both the cold beverages portfolio and Keurig brewer and pod sales recovery. CEO Tim Cofer, who joined from Mondelez International in 2023, has prioritized revenue management (balancing price and volume), operational efficiency, and brand investment across KDP's portfolio of over 125 owned, licensed, and partner brands. Keurig Dr Pepper was formed through the 2018 merger of Keurig Green Mountain (coffee systems) and Dr Pepper Snapple Group (beverages), controlled by JAB Holding Company (a Luxembourg-based holding company of the Reimann family).
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.